Stockreport

Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer [Yahoo! Finance]

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF While clinically successful, first-generation BTEs suffer a short half-life. Now, Wistar scientists have built upon BTE technology to develop new and improved recombinan [Read more]